Peer-Reviewed Publication
Eur Heart J Digit Health2026;7(5):ztag072.June 1, 2026Journal Article
A digital health program enhances walking capacity and health status in symptomatic peripheral artery disease.
Vishal Amlani1,2, Bartosz Dobies3, Carl-Magnus Wahlgren4, Manne Andersson5,6, Birgitta Sigvant7, Anders Gottsäter8, Moncef Zarrouk9, Olga Nilsson4, Hallur Hallsson3, Linda Karlsdottir3, Sæmundur Oddsson3, Tryggvi Thorgeirsson3, Joakim Nordanstig1,2
1Institute of Medicine, Department of Molecular and Clinical Medicine, University of Gothenburg, Sweden.
2Department of Vascular Surgery, Sahlgrenska University Hospital, 413 45 Gothenburg, Sweden.
3Sidekick Health Digital Therapeutics®, Kopavogur, Iceland.
4Department of Vascular Surgery, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
5Department of Biomedical and Clinical Sciences, Faculty of Health Sciences, Linköping University, Linköping, Sweden.
6Department of Surgery, Ryhov Hospital, Jönköping, Sweden.
7Region Värmland, Centre for Clinical Research and Education, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
8Lund University, Department of Medicine, Skåne University Hospital, Malmö, Sweden.
9Vascular Centre, Department of Cardiothoracic and Vascular Surgery, Skåne University Hospital, Malmö, Sweden.
Abstract
AIMS: Intermittent claudication (IC) is the most common manifestation of peripheral artery disease (PAD), an atherosclerotic condition associated with high cardiovascular morbidity and mortality. Management targets cardiovascular risk reduction and limb function, but effective non-invasive treatments for limb symptoms remain limited. The aim of this prospective, multicentre randomized controlled t…
Create a free account to keep reading
Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.
Want unlimited research access? See Pro plans